NEUVÉ Health review

The catalog is laid out the way a low-dose reader would design it: every GLP-1 product carries a microdose tier priced beneath the standard-dose version of the same thing, on the same card, so the saving is visible rather than reconstructed — injectable and sublingual, semaglutide and tirzepatide, with and without B12. A daily sublingual means the low dose is available without a needle. What is unresolved is what any of those figures actually covers. The weight-loss page is headed with all-in monthly pricing, its own fine print says the medication, the labs and the supplies are billed separately by an independent clinical partner, and every plan card lists the compounded medication among its inclusions. The partner that would settle it is never named. Four different starting figures are advertised across the site, one of which belongs to a testosterone product rather than a GLP-1, three membership tiers are named once and priced nowhere, and every legal page closes by saying it is summary copy under review by counsel that may change before public launch — on a site already taking intake.

Vs median

$7/mo above the $172 median across the 254 of 393 programs we track that publish a plain monthly rate

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Charges less for less

Consult

Billed separately

Dietitian

Not included

Labs

Optional

Pricing

Varies by dose, plan or tier

Price last updated

September 2026

NEUVÉ Health dispenses through a 503A and 503B claimed — no pharmacy named facility. Bloodwork is offered but not required. A clinician review is billed separately.

NEUVÉ Health prices a microdose on every GLP-1 product it sells — injectable and sublingual, semaglutide and tirzepatide, with and without B12 — and each one sits beneath the standard-dose version of the same product on the same card. As a shape that is close to ideal for a reader intending to stay small, and the sublingual line means the low dose is available without a needle. The problem is what the figure covers. The weight-loss page is headed all-in monthly pricing, its own fine print says medication, labs and treatment supplies are billed separately by an independent clinical partner, and every plan card lists the compounded medication as included; the partner that would settle it is never named. Four different starting figures are advertised across the site, one of which is a testosterone price rather than a GLP-1 one, and three membership tiers are named once in the financial policy and priced nowhere. Every legal page closes by saying it is plain-English summary copy under review by counsel and may be updated before public launch, on a site already taking intake.

WHETHER THE MEDICATION IS INSIDE THE PRICE IS ANSWERED THREE DIFFERENT WAYS on three pages, and the clinical partner that would settle it is never named

• The tirzepatide sublingual microdose card lists compounded sublingual SEMAGLUTIDE microdose among its own inclusions
• Four different starting figures are advertised across the site, one of which is a testosterone price rather than a GLP-1 one
• Three membership tiers are named once in the financial policy and priced nowhere
• Every legal page says it is summary copy under review by counsel and may change before public launch, on a live site taking intake
• All fifty states and members in forty-plus states are printed on the same page without the distinction the about page draws
• No support phone number is published anywhere, and the contact address sits on a different domain from every other address on the site
• No pharmacy, medical group or individual prescriber is named, and no milligram is published
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

NEUVÉ Health is one of 393 low-dose GLP-1 programs we track, and 254 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• Sublingual troches and drops
• What microdosing GLP-1 costs
• What the evidence actually shows
• The true annual cost of a plan
• Microdose & reconstitution calculator